Back to dashboard
MedicaidPrior AuthMedium impact

Alaska Medicaid Pharmacy Update November 2022

Alaska Medicaid·AK · Pharmacy, Pain Management, Psychiatry +1 more·Pharmacy
Effective date
Jan 2, 2023
We identified it
Jun 21, 2026
Days to comply

Summary

Alaska Medicaid updated their Preferred Drug List (PDL) and added new prior authorization requirements for 22 specific medications effective January 2, 2023. Several high-cost medications including Empaveli, Leqvio, Spravato, and Tepezza now require prior authorization, while Celebrex was removed from the prior auth list.

Action Required

Action needed
By January 2, 2023: Billing team must update prior authorization workflows for 22 medications including Empaveli, Leqvio, Spravato, Tepezza, and Voxzogo. Download updated clinical criteria and prior authorization forms from Alaska Medicaid website. Providers must ensure ICD-10 codes are included for all C-II opioid prescriptions and check PDMP before prescribing opioids. Claims for medications requiring prior auth will be denied without proper authorization.